Advanced search
Publication Cover
Renal Failure Volume 44, 2022 - Issue 1
Submit an article Journal homepage
2,328
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study

Masato Tashiroa Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;b Nagasaki University Infection Control and Education Center, Nagasaki University Hospital, Nagasaki, JapanCorrespondence[email protected]
View further author information
,
Yoko Obatac Department of Nephrology, Nagasaki University Hospital, Nagasaki, JapanView further author information
,
Takahiro Takazonoa Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;d Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, JapanView further author information
,
Yuki Otac Department of Nephrology, Nagasaki University Hospital, Nagasaki, Japan;e Department of Nephrology, Sasebo City General Hospital, Nagasaki, JapanView further author information
,
Tomotaro Wakamuraf Medical Affairs Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, JapanView further author information
,
Yui Shiozawag Deloitte Tohmatsu Consulting LLC, Tokyo, JapanView further author information
,
Ai Tsuyukig Deloitte Tohmatsu Consulting LLC, Tokyo, JapanView further author information
,
Taiga Miyazakia Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;d Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, JapanView further author information
,
Tomoya Nishinoc Department of Nephrology, Nagasaki University Hospital, Nagasaki, JapanView further author information
&
Koichi Izumikawaa Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan;b Nagasaki University Infection Control and Education Center, Nagasaki University Hospital, Nagasaki, JapanView further author information
 show all
Pages 282-292 | Received 13 Jun 2021, Accepted 22 Jan 2022, Published online: 16 Feb 2022

References

  • Kleinberg M. Aspergillosis in the CLEAR outcomes trial: working toward a real-world clinical perspective. Med Mycol. 2005;43(Suppl 1):S289–S294.
  • Brown JM. Fungal infections in bone marrow transplant patients. Curr Opin Infect Dis. 2004;17(4):347–352.
  • Marr KA, Carter RA, Crippa F, et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34(7):909–917.
  • Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol. 2005;43(Suppl 1):S49–S58.
  • O’Brien SN, Blijlevens NMA, Mahfouz TH, et al. Infections in patients with hematological cancer: recent developments. Hematology Am Soc Hematol Educ Program. 2003;2003(1):438–472.
  • Stone NR, Bicanic T, Salim R, et al. Liposomal amphotericin B (AmBisome(®)): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs. 2016;76(4):485–500.
  • Barrett JP, Vardulaki KA, Conlon C, Amphotericin B Systematic Review Study Group, et al. A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations. Clin Ther. 2003;25(5):1295–1320.
  • Karimzadeh I, Khalili H, Farsaei S, et al. Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity. Eur J Clin Pharmacol. 2013;69(7):1351–1368.
  • Loo AS, Muhsin SA, Walsh TJ. Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B. Expert Opin Drug Saf. 2013;12(6):881–895.
  • Yamazaki H, Kondo T, Aoki K, et al. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: a retrospective analysis. Diagn Microbiol Infect Dis. 2018;90(2):123–131.
  • Saito Y, Horita E, Uesaka T, et al. Factor analysis in decreased expression of renal function by liposomal-amphotericin B. J Pharm Health Care Sci. 2014;40(2):94–99.
  • Takazono T, Tashiro M, Ota Y, et al. Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan. Sci Rep. 2020;10(1):15033.
  • Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
  • Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–992.
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.
  • Krajewski ML, Raghunathan K, Paluszkiewicz SM, et al. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg. 2015;102(1):24–36.
  • Mayer J, Doubek M, Doubek J, et al. Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study. J Infect Dis. 2002;186(3):379–388.
  • Karimzadeh I, Farsaei S, Khalili H, et al. Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity. Expert Opin Drug Saf. 2012;11(6):969–983.
  • Girmenia C, Cimino G, Di Cristofano F, et al. Effects of hydration with salt repletion on renal toxicity of conventional amphotericin B empirical therapy: a prospective study in patients with hematological malignancies. Support Care Cancer. 2005;13(12):987–992.
  • Karimzadeh I, Sepehr-Sobhani A, Khoshnoud MJ, et al. Comparison of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration alone in reducing amphotericin B nephrotoxicity: a randomized clinical trial. Res Pharm Sci. 2020;15(6):583–591.
  • Vora S. Acute renal failure due to vancomycin toxicity in the setting of unmonitored vancomycin infusion. Proc (Bayl Univ Med Cent). 2016;29(4):412–413.
  • Zager RA, Bredl CR, Schimpf BA. Direct amphotericin B-mediated tubular toxicity: assessments of selected cytoprotective agents. Kidney Int. 1992;41(6):1588–1594.
  • Heyman SN, Stillman IE, Brezis M, et al. Chronic amphotericin nephropathy: morphometric, electron microscopic, and functional studies. JASN. 1993;4(1):69–80.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.